“It’s not good. When you’re talking about higher costs and lower production volumes, it’s a lethal combination,” said Nick Xanders, who heads European equity strategy at BTIG, the trading and brokerage firm. “It’s symptomatic of the entire market, with costs rising but revenues not coming through. Some hope that it’s a company thing, but I don’t think it is.”